We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
DaVita
DVA
$15B
| $5.51M | 0.07% |
54,800
+47,080
| +610% | +$4.37M |
|
277
Universal Health Services
UHS
$10.2B
| $5.46M | 0.06% |
34,611
-89,240
| -72% | -$12.4M |
|
|
CORS
278
DELISTED
Corsair Partnering Corporation
CORS
| $5.44M | 0.06% |
525,001
| – | – |
|
279
Olema Pharmaceuticals
OLMA
$985M
| $5.31M | 0.06% |
+588,052
| New | +$3.55M |
|
280
Larimar Therapeutics
LRMR
$413M
| $5.26M | 0.06% |
1,681,913
| – | – |
|
281
NVIDIA
NVDA
$5.01T
| $5.21M | 0.06% |
123,120
-329,590
| -73% | -$10.9M |
|
282
Krystal Biotech
KRYS
$9.21B
| $5.19M | 0.06% |
+44,223
| New | +$4.52M |
|
|
BFK
283
DELISTED
BlackRock Municipal Income Trust
BFK
| $5.15M | 0.06% |
518,150
-213,008
| -29% | -$2.11M |
|
|
PRO
284
DELISTED
PROS Holdings
PRO
| $5.14M | 0.06% |
166,892
+5,985
| +4% | +$168K |
|
285
Evolent Health
EVH
$353M
| $5.11M | 0.06% |
+168,500
| New | +$5.45M |
|
286
Amdocs
DOX
$5.88B
| $5.08M | 0.06% |
51,422
-16,709
| -25% | -$1.57M |
|
|
IPG
287
DELISTED
Interpublic Group of Companies
IPG
| $5.04M | 0.06% |
130,676
-578,979
| -82% | -$21.8M |
|
288
Arcus Biosciences
RCUS
$3.47B
| $5.04M | 0.06% |
+248,000
| New | +$4.72M |
|
289
BridgeBio Pharma
BBIO
$15.7B
| $4.99M | 0.06% |
290,000
-23,195
| -7% | -$349K |
|
290
Teladoc Health
TDOC
$1.21B
| $4.97M | 0.06% |
+196,235
| New | +$4.94M |
|
|
FORG
291
DELISTED
ForgeRock, Inc.
FORG
| $4.95M | 0.06% |
241,204
-163,128
| -40% | -$3.27M |
|
292
Exelixis
EXEL
$13.8B
| $4.95M | 0.06% |
+259,000
| New | +$4.99M |
|
293
BioNTech
BNTX
$23.3B
| $4.94M | 0.06% |
+45,800
| New | +$5.15M |
|
|
VTYX
294
DELISTED
Ventyx Biosciences
VTYX
| $4.92M | 0.06% |
150,000
+23,286
| +18% | +$803K |
|
|
FDEU
295
DELISTED
First Trust Dynamic Europe Equity Income Fund
FDEU
| $4.91M | 0.06% |
374,816
| – | – |
|
|
EOCW
296
DELISTED
Elliott Opportunity II Corp.
EOCW
| $4.91M | 0.06% |
474,000
| – | – |
|
297
Pool Corp
POOL
$7.11B
| $4.86M | 0.06% |
12,963
-75,236
| -85% | -$25.7M |
|
298
Aurinia Pharmaceuticals
AUPH
$1.87B
| $4.84M | 0.06% |
500,000
-453,462
| -48% | -$4.71M |
|
299
Acadia Healthcare
ACHC
$2.85B
| $4.77M | 0.06% |
59,896
-4,340
| -7% | -$314K |
|
|
SUM
300
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $4.72M | 0.06% |
+124,668
| New | +$3.86M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.